Effects of simvastatin (40 and 80 mg) on highly sensitive C-reactive protein in patients with combined hyperlipidemia

American Journal of Cardiology

Volumn 89, Issue 4, 2002, Pages 468-469

  Miller, Michael ^a   Jialal, Ishwarlal ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CERIVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ASSAY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHORT SURVEY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037083101     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02273-1     Document Type: Article

References (11)

1. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
2. Inflammation markers and coronary heart disease
3. CRP adds to the predictive value of total HDL - Cholesterol in determining risk of first MI
4. CRP and other markers of inflammation in the prediction of CAD in women
5. HsCRP - A novel and promising marker of CHD
6. Long-term effects of pravastatin on plasma concentration of C-reactive protein
7. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels
8. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
9. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia
10. Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia
11. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease; the Scandinavian Survival Study